Zecuity (sumatriptan iontophoretic transdermal system) Removed from Market

  Teva Pharmaceuticals, the makers of the transdermal patch Zecuity (Sumatriptan Iontophoretic Transdermal System ) has temporarily suspended the sales, marketing and distribution of this medication. Teva has done a voluntary recall of this medication and is working with the FDA to examine all reported adverse skin reactions related to the medication. The Transdermal patch was … Continued

Imodium A-D and Overdosage FDA Releases Safety Announcement

The FDA recently release a safety announcement warning consumers that high doses of the antidiarrheal medicine loperamide(Imodium) or Imodium A-D can lead to serious heart problems that can lead to death. These heart problems include abnormal heart rate either rapid or irregular. When high doses of Loperamide are taken by itself or in combination with … Continued

Abilify Gambling Addiction & Compulsive Behavior Investigation

                          A growing number of Abilify Lawsuits are being filed by patients who have suffered compulsive behaviors after taking Abilify. Uncontrollable gambling has been associated with the antipsychotic drug Abilify (aripiprazole), a drug used to cure mental illnesses such as manic depression, autism, … Continued

Zithromax Z-Pak, Zmax, Azithromycin Side Effects Investigation

Generically known as azithromycin, Zithromax, also known as Z-Pak or Zmax is facing a rising number of lawsuits associated with increased risk of cardiovascular death. First introduced by Pfizer in 1991, Zithromax belong to a group of drugs known as macrolides which works by slowing down bacterial growth as it prevents the bacteria’s protein production. … Continued

Testosterone Gel (T-Gel) & Cream Side Effects Investigation

A rising number of lawsuits in the United States are being filed by men who have experienced cardiovascular complications from testosterone therapy side effects. Testosterone therapy is available and can be delivered as a gel, pill, implant, patch or injection. These prescription testosterone therapies have been associated with an increased risk of cardiac problems among … Continued

Bleeding, Blood Clots, Ischemic Stroke Xarelto Side Effects Investigation

Janssen Pharmaceutical, manufacturer of a popular anticoagulant Xarelto (rivaroxaban), and co-maker Bayer Healthcare, are facing several lawsuits associated with serious side effects of fatal internal bleeding. Released in 2011, Xarelto has been one of the most prescribed blood thinners. It is widely recommended to help prevent blood clots in patients suffering from stroke, pulmonary embolism, … Continued

Is Risperdal Causing Male Breast Growth Investigation

Manufacturer of the antipsychotic drug Risperdal (risperidone), Johnson & Johnson, is facing a growing number of allegations that young boys throughout the United States have developed male breast tissue because of the medication. Studies show that side effects of Risperdal may cause a condition known as gynecomastia, the abnormal breast growth or enlargement among male … Continued

Melanoma Skin Cancer Investigation from taking Viagra, Levitra, Cialis

New York City-based pharmaceutical leader, Pfizer, manufacturer of the well-known and most popular male Erectile Dysfunction drug (ED), Viagra (sildenafil), is facing countless number of lawsuits from patients who have been diagnosed with melanoma after taking the medication. In April 2014, the Journal of the American Medical Association (JAMA) published the results of a study … Continued

Prilosec, Nexium Acid Reflux Medication Side Effects:Investigation into Heart Attack

AstraZeneca, manufacturer of popular heartburn drugs, Nexium and Prilosec is facing a rising number of lawsuits from people throughout the United States alleging that they have suffered heart attacks after taking these acid reflux medications. Recent studies from Stanford University show that proton pump inhibitor (PPI) heartburn medications such as Prilosec 213 may be linked … Continued

Onglyza, Kombiglyze: Heart Failure, Pancreatic Cancer, Thyroid Cancer Investigation

Manufactured by AstraZeneca and Bristol-Myers Squibb, Onglyza (saxagliptin) and Kombiglyze XR (saxagliptin and metformin HCI extended-release) Type 2 diabetes medications are facing a rising number of lawsuits nationwide. Onglyza and Kombiglyze belong to a group of Type 2 diabetes medications called DPP-4 inhibitors and victims throughout the United States have sparked safety concerns regarding potential … Continued